Clinical Trial Update: A Study of the Efficacy and Safety of Pregabalin as Add-On Therapy for Partial Onset Seizures in Children Ages 4-16 Years [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating pregabalin as add-on therapy for partial onset seizures in children aged 4-16; completed with results posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy
• Partial Seizures

Drugs mentioned

• Pregabalin (Pregabalin)

Snippet

Sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | Conditions: Epilepsy, Partial Seizures | Phase 3 | Status: COMPLETED | Results posted: 2017-03-21